• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.

作者信息

Varesio L, Giovarelli M, Landolfo S, Forni G

出版信息

Cancer Res. 1979 Dec;39(12):4983-8.

PMID:159126
Abstract
摘要

相似文献

1
Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.自发性肿瘤进展过程中增殖反应和淋巴因子产生的抑制
Cancer Res. 1979 Dec;39(12):4983-8.
2
The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.肿瘤衍生细胞因子对携带乳腺腺癌小鼠免疫系统的作用。I. 通过体内给予重组粒细胞-巨噬细胞集落刺激因子（rGM-CSF）诱导正常小鼠产生调节性巨噬细胞。
J Immunol. 1991 Jan 15;146(2):783-9.
3
Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.荷瘤小鼠巨噬细胞异常的抗原呈递参与其T细胞反应的下调。
J Immunol. 1995 Sep 15;155(6):3124-34.
4
Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.大鼠T细胞针对同基因乳腺腺癌13762A产生的抑制性淋巴因子。
Cancer Res. 1988 Feb 15;48(4):943-9.
5
Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.肿瘤衍生细胞因子对荷乳腺腺癌小鼠免疫系统的作用。II. 肿瘤衍生的粒细胞巨噬细胞集落刺激因子对巨噬细胞介导的细胞毒性的下调作用
J Immunol. 1991 Oct 15;147(8):2816-23.
6
Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.乳腺肿瘤发生过程中的脾脏改变：对不同免疫参数的多样影响。
Anticancer Res. 1981;1(2):63-9.
7
Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.源自鼠类乳腺肿瘤的粒细胞巨噬细胞集落刺激因子对免疫调节性巨噬细胞的扩增作用
Cancer Res. 1990 Jan 15;50(2):227-34.
8
IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.白细胞介素-11诱导的C/EBP转录因子结合减少可能导致荷瘤小鼠中白细胞介素-12的下调。
Int J Oncol. 2003 Feb;22(2):439-48.
9
[Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].[淋巴细胞与肿瘤细胞混合培养中巨噬细胞移动抑制因子的产生动力学]
Biull Eksp Biol Med. 1982 Feb;93(2):53-5.
10
In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.淋巴因子在体外诱导杀肿瘤和抑制性巨噬细胞：可能的反馈调节
J Immunol. 1981 Jun;126(6):2123-8.

引用本文的文献

1
Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.髓源性抑制细胞在癌症中对 L-精氨酸的代谢：T 细胞抑制的机制和治疗前景。
Immunol Invest. 2012;41(6-7):614-34. doi: 10.3109/08820139.2012.680634.
2
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.髓源性抑制细胞对精氨酸的调节与癌症中的耐受性：机制与治疗前景
Immunol Rev. 2008 Apr;222:180-91. doi: 10.1111/j.1600-065X.2008.00608.x.
3
Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
大鼠肿瘤诱导的抑制性巨噬细胞：它们对刀豆蛋白A和植物血凝素反应的抑制作用差异。
Clin Exp Immunol. 1984 Aug;57(2):371-9.
4
Effects of the removal of adherent and phagocytic cells on the spleen cell lymphoproliferative response of tumor-bearing mice.去除黏附细胞和吞噬细胞对荷瘤小鼠脾细胞淋巴细胞增殖反应的影响。
Cancer Immunol Immunother. 1985;20(2):97-102. doi: 10.1007/BF00205674.
5
Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.对携带腺癌13762的Fischer大鼠脾脏巨噬细胞免疫抑制作用的调节
Cancer Immunol Immunother. 1985;20(2):167-74. doi: 10.1007/BF00205684.
6
Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.癌症患者自体细胞毒性反应效应阶段的抑制细胞。
Cancer Immunol Immunother. 1988;27(2):147-53. doi: 10.1007/BF00200020.